Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC).

被引：53

作者：

Birtle, Alison Jane

Chester, John David

Jones, Robert Jones

Johnson, Mark

Hill, Michaela

Bryan, Richard T.

Catto, James

Donovan, Jenny

French, Ann

Harris, Chris

Keeley, Francis

Kockelbergh, Roger

Powles, Thomas

Todd, Rachel

Tregellas, Lucy

Wilson, Caroline

Winterbottom, Andrew

Lewis, Rebecca

Hall, Emma

机构：

[1] Royal Preston Hosp, Rosemere Canc Ctr, Preston, Lancs, England

[2] Cardiff Univ, Cardiff, Wales

[3] Univ Glasgow, Beatson W Scotland Canc Ctr, Glasgow, Lanark, Scotland

[4] Newcastle Tyne Hosp NHS Trust, Newcastle, NSW, Australia

[5] Inst Canc Res, Clin Trials & Stat Unit, London, England

[6] Univ Birmingham, Birmingham, England

[7] Univ Sheffield, Sheffield, S Yorkshire, England

[8] Univ Bristol, Bristol, England

[9] Southend Univ Hosp NHS Fdn Trust, Southend On Sea, England

[10] Consumer Representat, London, England

[11] N Bristol NHS Trust, Bristol, England

[12] Univ Hosp Leicester, Leicester, Leics, England

[13] Barts Hlth NHS Trust St Bartholomews Hosp, London, England

[14] Inst Canc Res, Clin Trials & Stat Unit, London, England

[15] Inst Canc Res, Clin Trials & Stat Unit, Sutton, Surrey, England

[16] Fight Bladder Canc, Chinnor, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期

关键词：

D O I：

10.1200/JCO.2018.36.6_suppl.407

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

407

引用

页数：1

共 50 条

[31] Neoadjuvant nivolumab (N) plus ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC): Updated results.
Sternschuss, Michal
Guercio, Brendan John
Pietzak, Eugene J.
Ponomarev, Maria
Regazzi, Ashley M.
Quinlan, Colleen
Aggen, David H.
Goh, Alvin C.
Cha, Eugene K.
Donat, S. Machele
Hakimi, A. Ari
Matulewicz, Richard
Funt, Samuel A.
Bajorin, Dean F.
Iyer, Gopa
Ostrovnaya, Irina
Al-Ahmadie, Hikmat A.
Rosenberg, Jonathan E.
Coleman, Jonathan
Teo, Min Yuen
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 645 - 645
[32] A phase III randomised clinical trial of perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB): study protocol
Engineer, Reena
Patkar, Shraddha
Lewis, Shirley Christabel
Das Sharma, Ashutosh
Shetty, Nitin
Ostwal, Vikas
Ramaswamy, Anant
Chopra, Supriya
Agrawal, Archi
Patil, Prachi
Mehta, Shaesta
Goel, Mahesh
BMJ OPEN, 2019, 9 (06):
[33] EFFICACY AND SAFETY OF PADELIPORFIN VASCULAR TARGETED PHOTODYNAMIC THERAPY (VTP) FOR TREATMENT OF LOW-GRADE UPPER TRACT UROTHELIAL CANCER (LG UTUC): PHASE 3 PRELIMINARY RESULTS
Coleman, Jonathan
Shore, Neal
Marcq, Gautier
Colombel, Marc
Psutka, Sarah
Raman, Jay
Margulis, Vitaly
Singla, Nirmish
Djaladat, Hooman
Aigner, Reinhard
Raventos Busquets, Carles Xavier
Amato, Gianni
Cohen, Yaniv
Mroz, Axelle
Koudinova, Natalia
Krasnopolskaya, Inna
Alpert, Genia
Scherz, Avigdor
Kaufman, Ronald
JOURNAL OF UROLOGY, 2024, 211 (05): : E446 - E447
[34] Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer:: a multicentre randomised controlled phase III trial
Nordlinger, B
Rougier, P
Arnaud, JP
Debois, M
Wils, J
Ollier, JC
Grobost, O
Lasser, P
Wals, J
Lacourt, J
Seitz, JF
dos Santos, JG
Bleiberg, H
Mackiewickz, R
Conroy, T
Bouché, O
Morin, T
Baila, L
van Cutsem, E
Bedenne, L
LANCET ONCOLOGY, 2005, 6 (07): : 459 - 468
[35] RADIOGRAPHIC PREDICTORS OF PATHOLOGIC RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH HIGH-GRADE UPPER TRACT UROTHELIAL CARCINOMA: RESULTS OF A PHASE 2 CLINICAL TRIAL
Wong, Nathan C.
Sjoberg, Daniel
Ghafoor, Soleen
Vargas, H. Alberto
Silva, Nicholas
Bochner, Bernard H.
Dalbagni, Guido
Donat, S. Machele
Herr, Harry W.
Cha, Eugene
Donahue, Timothy
Pietzak, Eugene
Al-Ahmadie, Hikmat
Benfante, Nicole
Iyer, Gopa
Teo, Min Yuen
Rosenberg, Jonathan E.
Bajorin, Dean F.
Coleman, Jonathan A.
JOURNAL OF UROLOGY, 2020, 203 : E375 - E375
[36] Sequential versus standard chemotherapy in advanced non-small cell lung cancer (NSCLC): A phase III randomised trial
Paesmans, M.
Berghmans, T.
Lafitte, J. J.
Lecomte, J.
Alexopoulos, C. G.
Van Cutsem, O.
Giner, V.
Efremidis, A.
Scherpereel, A.
Sculier, J. P.
LUNG CANCER, 2006, 52 : S26 - S27
[37] Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial
Koopman, Miriam
Antonini, Ninja F.
Douma, Joep
Wals, Jaap
Honkoop, Aafke H.
Erdkamp, Frans L. G.
de Jong, Robert S.
Rodenburg, Cees J.
Vreugdenhil, Gerard
Loosveld, Olaf J. L.
van Bochove, Aart
Sinnige, Harm A. M.
Creemers, Geert-Jan M.
Tesselaar, Margot E. T.
Slee, Peter H. Th J.
Werter, Marjon J. B. P.
Mol, Linda
Dalesio, Otilia
Punt, Cornelis J. A.
LANCET, 2007, 370 (9582): : 135 - 142
[38] WUTSUP-01: Phase II trial of neoadjuvant toripalimab and chemotherapy in locally advanced upper tract urothelial carcinoma
Liao, X.
Zhang, P.
Liu, J.
Zhang, S.
Wei, Q.
Bao, Y.
ANNALS OF ONCOLOGY, 2023, 34 : S1562 - S1562
[39] Neoadjuvant combined chemotherapy and immunotherapy for upper tract urothelial carcinoma: Preliminary results from a phase II study.
Bi, Xin-Gang
Zhang, Wen
Xie, Yaoyu
Wu, Jie
Cui, Honglei
Cao, Chuanzhen
Lu, Li
Wen, Li
Guan, Youyan
Shi, Hongzhe
Xiao, Zhendong
Jiang, Zhichao
Sun, Yongkun
Zheng, Shan
Zhang, Jin
Zhou, Aiping
Shou, Jianzhong
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 636 - 636
[40] Prostate cancer and hypofractionation: reflections on recent randomised phase III clinical trial results
Dearnaley, David
Hall, Emma
TRANSLATIONAL ANDROLOGY AND UROLOGY, 2017, 6 (01) : 134 - 136

← 1 2 3 4 5 →